FDA Brief

Warning letters Drugs

FDA warning letter to

Mirfeel Korea Co., Ltd.

High riskIssued Jun 22, 2022Posted Jun 28, 2022Center for Drug Evaluation and Research | CDER

Mirfeel Korea's hand sanitizer contained benzene and had testing failures; FDA also says food-pouch packaging misbranded.

What happened

FDA laboratory testing of a batch in U.S. distribution found benzene at 5 to 6 ppm in MOISTURIZING HAND SANITIZER Peppermint Scented made at Mirfeel's facility. FDA also reviewed records the firm submitted after an August 3, 2021 request and found violations of current good manufacturing practice (CGMP). FDA cited the 1.01 ounce hand sanitizer containers as misbranded because they resemble food pouches.

What FDA found

  1. FDA found benzene at 5 to 6 ppm in a hand sanitizer batch made at the facility, showing quality assurance was not working under CGMP.

    FD&C Act section 501(a)(2)(B) (21 U.S.C. 351(a)(2)(B))
  2. The firm did not perform appropriate finished-product testing, including identity and strength of the active ingredient, before releasing hand sanitizer.

    21 CFR 211.165(a)
  3. The firm relied on supplier certificates of analysis without doing at least one identity test for each incoming component lot and without verifying supplier test reliability.

    21 CFR 211.84(d)(1) and 21 CFR 211.84(d)(2)
  4. The firm lacked an adequate stability program and did not provide expiry dates; stability tests covered only appearance and physical characteristics.

    21 CFR 211.166(a)
  5. The 1.01 ounce hand sanitizer containers resemble food pouches, which FDA says can mislead consumers and risk accidental ingestion.

    FD&C Act section 502(i)(1) (21 U.S.C. 352(i)(1))

What FDA wants

FDA tells Mirfeel to respond in writing within 15 working days with corrective actions, including a benzene investigation, raw material and batch lists, complete batch records, impurity testing for all unexpired U.S. batches, and a stability-program CAPA. FDA also strongly recommends a qualified CGMP consultant.

Who should pay attention

  • brands and retailers selling Mirfeel hand sanitizer
  • U.S. importers and distributors of OTC hand sanitizer
  • hand sanitizer ingredient suppliers and contract manufacturers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Owen Biosciences, Inc.

    Owen Biosciences' over-the-counter benzoyl peroxide acne lotion had over 20 parts per million benzene and lacked release testing.

    High risk
  2. Accra-Pac, Inc. dba Voyant Beauty

    Voyant Beauty's Elkhart, Indiana plant made OTC aerosol drugs contaminated with benzene and failed to investigate or test properly.

    High risk
  3. Salon Technologies International, Inc.

    FDA warns Salon Technologies International that its hand sanitizers contained unacceptable acetaldehyde, acetal and benzene impurities and were adulterated.

    High risk
  4. Virgin Scent Inc. dba Artnaturals

    FDA warns Artnaturals after hand sanitizer tests found benzene and acetaldehyde impurities and inspection found CGMP failures.

    High risk